Researchers tested more than 65,000 patients with more than 30 solid tumor types and found the rate of HER2 positivity was about 3%.

Boster Bio pioneers free antibody validation, revolutionizing IHC services with guaranteed reagent reliability, setting new standards for reproducible research in biotech and pharmaceutical ...

Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization ...

Clinical trial updates in cancer care include a remote study in small cell lung cancer and new findings in ovarian, solid ...

Toripalimab is an anti-PD-1 monoclonal antibody developed for its ability to block PD-1 interactions with its ligands, PD-L1 and PD-L2, and to induce PD-1 receptor internalization (endocytosis ...

The diagnosis of a suspected lung, head, and neck cancer called NUT carcinoma should include additional testing capable of ...

These establishments in Wayne County were inspected between July 14 and 27, according to Pennsylvania Department of ...

For example, automated immunohistochemistry (IHC) testing has already begun at LUTH-NHIS, enabling timely and accurate diagnoses.

AZ's head of oncology and haematology, Dave Fredrickson, said the approval "highlights the importance of testing metastatic breast cancer tumours for detectable staining with a standard IHC test ...

An artificial intelligence-based image analysis model has more accurately predicted cancer biomarkers and outcomes compared with conventional methods.

Agilent Technologies has introduced three new models in its Dako Omnis line of staining instruments, designed to support ...

Amgen (NASDAQ:AMGN) today announced financial results for the second quarter of 2025.